ArticleVeterinary research communications2026
Tracing feline herpesvirus-1 exposure in domestic cats from Namibia: associations with neutralising antibodies, vaccination, clinical signs, and retroviral status.
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Feline herpesvirus type 1 (FHV-1) is a major cause of upper respiratory and ocular disease in domestic cats and remains widely distributed worldwide. However, information on FHV-1 exposure and neutralising antibody responses in cats from Namibia is limited. This study assessed FHV-1 neutralising antibody prevalence in a convenience sample of 236 domestic cats sampled across 15 towns in eight regions of Namibia. Neutralising antibodies were detected in 18/236 (8%) cats (95% CI: 4.88-11.73%). Seropositive animals were identified only in Erongo, Khomas, and Hardap regions, with the highest regional seroprevalence observed in Erongo. Seropositivity was uncommon in both vaccinated and unvaccinated cats and was not significantly associated with vaccination status, feline immunodeficiency virus antibody status, or feline leukaemia virus antigen status. A significant association was identified between seropositivity and oculonasal discharge (p < 0.001). Overall, the findings indicate low FHV-1 neutralising antibody prevalence within the sampled population rather than the wider domestic cat population of Namibia, and suggest that detectable neutralising antibodies were observed predominantly in unvaccinated cats, although interpretation is limited by the small number of vaccinated animals and the absence of detailed vaccination histories.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.